Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bionomy Health vs RxSpan MD

Bionomy Health
Graded #70

Lower grade

vs+13.200000000000003
RxSpan MD
Graded #4

Higher grade

The verdict

RxSpan MD takes it — 86.8/100 to 73.6/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxSpan MD +18
68
86
Dose & formulationRxSpan MD +4
85
89
Clinical oversightRxSpan MD +10
78
88
Labs & monitoringRxSpan MD +31
52
83
FulfillmentBionomy Health +5
94
89
Contract termsRxSpan MD +24
61
85
Bionomy Health · left barRxSpan MD · right bar

The numbers

MetricBionomy HealthRxSpan MD
WeighScore73.6/10086.8/100
GradeCB
Scorecard rank#70#4
Semaglutide$189/moFrom $194/mo
Tirzepatide$249/mo$329/mo
Coverage48 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Bionomy Health

Graded #70 · C

Strengths

  • Offers both compounded semaglutide (189/mo) and tirzepatide (249/mo) with pay-per-prescription pricing and no subscription
  • Physician-led with a free, physician-reviewed intake before you pay anything
  • Fills through LegitScript-certified compounding pharmacies Strive and Absolute; available in 48 states
  • Pairs GLP-1 protocols with muscle-preserve supplements and a written training note to protect lean mass

Where it loses points

  • Men's health brand, so the site framing and protocols are geared to men rather than a general audience
  • New brand launched in 2026 with limited independent reviews and track record
  • Not available in Alaska or Hawaii; compounded medications are not FDA-approved
RxSpan MD

Graded #4 · B

Strengths

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
  • Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Published pricing is for the compounded line — brand-name pricing isn’t itemized
  • A prescription isn’t guaranteed — a provider reviews eligibility after checkout

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard